Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure

Gottschalk, M. G.
Mortas, P.
Haman, M.
Özcan Kabasakal, Süreyya
Biemans, B.
Bahn, S.
While anhedonia is considered a core symptom of major depressive disorder (MDD), less attention has been paid to cognitive dysfunctions. We evaluated the behavioural and molecular effects of a selective serotonin re-uptake inhibitor (SSRI, fluoxetine) and an acetylcholinesterase inhibitor (AChEI, donepezil) on emotional-cognitive endophenotypes of depression and the hippocampal proteome. A chronic social defeat (SD) procedure was followed up by "reminder" sessions of direct and indirect SD. Anhedonia-related behaviour was assessed longitudinally by intracranial self-stimulation (ICSS). Cognitive dysfunction was analysed by an object recognition test (ORT) and extinction of fear memory. Tandem mass spectrometry (MSE) and protein protein -interaction (PPI) network modelling were used to characterise the underlying biological processes of SD and SSRI/AChEl treatment. Independent selected reaction monitoring (SRM) was conducted for molecular validation. Repeated SD resulted in a stable increase of anhedonia-like behaviour as measured by ICSS. Fluoxetine treatment reversed this phenotype, whereas donepezil showed no effect. Fluoxetine improved recognition memory and inhibitory learning in a stressor-related context, whereas donepezil only improved fear extinction. MSE and PPI network analysis highlighted functional SD stress-related hippocampal proteome changes including reduced glutamatergic neurotransmission and learning processes, which were reversed by fluoxetine, but not by donepezil. SRM validation of molecular key players involved in these pathways confirmed the hypothesis that fluoxetine acts via increased AMPA receptor signalling and Ca2+-mediated neuroplasticity in the amelioration of stress-impaired reward processing and memory consolidation. Our study highlights molecular mediators of SD stress reversed by SSRI treatment, identifying potential viable future targets to improve cognitive dysfunctions in MDD patients. (C) 2017 Elsevier B.V. and ECNP. All rights reserved.


SAHIN, NH; SAHIN, N (Wiley, 1992-03-01)
The Dysfunctional Attitude Scale (DAS-A) has been used in many studies to measure depressogenic attitudes, vulnerability to depression and to assess the effectiveness of cognitive therapy. Despite its frequent use in research, no data have yet been reported on its item validity. The purpose of the present study was to investigate the item validity and psychometric properties of the DAS-A in the Turkish cultural context. The subjects were 345 university students. The locally adapted versions of the Beck ...
Weight Gain in Risperidone Therapy Investigation of Peripheral Hypothalamic Neurohormone Levels in Psychotic Patients
Yanık, Tülin; Sutcigil, Levent; Ak, Mehmet (Ovid Technologies (Wolters Kluwer Health), 2013-10-01)
The use of antipsychotic drugs has started a new era in the treatment of psychotic disorders. Nevertheless, they cause complications in the long-term treatment, which is mainly weight gain. In this study, we investigated circulating levels of hypothalamic neuropeptides, which are related to appetite regulation, neuropeptide Y (NPY), alpha-melanocyte-stimulating hormone (alpha-MSH), cocaine- and amphetamine-regulated transcript (CART), and leptin, in first-attack psychotic patients who were treated with an a...
Dysregulation of hypothalamic modulation in olanzapine treated male rats
Sezlev-Bilecen, Deniz; AK, MEHMET; Yanık, Tülin (Elsevier BV, 2016-11-03)
The mechanism of weight gain through application of olanzapine, a serotonin and dopamine receptor antagonist has not been fully understood. Weight gain and food intake are under the control of various neurohormones; POMC (proopiomelanocortin), CART (cocaine and amphetamine regulated transcript), AgRP (Agouti-related peptide) and NPY (neuropeptide Y) that are majorly synthesized and secreted from the arcuate nucleus (ARC) of hypothalamus. In this study, the alteration of the ARC neurohormone levels in rats w...
Neuropathic insult increases the responsiveness to acetic acid in mice
Gurdap, Cenk O.; Markwalter, Patrick S.; Neddenriep, Bradley; Bagdas, Deniz; Damaj, M. Imad (Ovid Technologies (Wolters Kluwer Health), 2019-09-01)
Chronic neuropathic pain is a burden to millions of patients every day. Patients with neuropathic pain will also experience acute pain throughout their everyday lives adding to their nociceptive burden. Using nociceptive models in mice this study aimed to investigate the relationship between acute visceral pain and chronic neuropathic pain in spontaneous and affective behaviors. Neuropathic pain was induced by chronic constriction injury (CCI) of the sciatic nerve of C57BL/6J male mice and examined in assay...
Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk
Turkanoglu, Aysun; Demirdogen, Birsen Can; Demirkaya, Seref; Bek, Semai; Adalı, Orhan (Springer Science and Business Media LLC, 2010-12-01)
Oxidative stress plays a major role in pathogenesis of atherosclerosis which is responsible for stroke. Glutathione S-transferases (GSTs) detoxify metabolites produced by oxidative stress within the cell and protect the cells against injury. This study aimed to investigate the association of polymorphisms in GSTT1, GSTM1 genes and GST activity with ischemic stroke risk. Patients had almost the same GST activity as that of controls. No significant differences were found between patients and controls in terms...
Citation Formats
M. G. Gottschalk, P. Mortas, M. Haman, S. Özcan Kabasakal, B. Biemans, and S. Bahn, “Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure,” EUROPEAN NEUROPSYCHOPHARMACOLOGY, pp. 195–210, 2018, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/42195.